Coller Capital related stories
All articles and analysis
PEI Awards 2023: Secondaries winnersThe top secondaries deals, firms, law firms and advisers of the year.
GP stakes and secondaries far from strange bedfellowsBlackstone’s decision to fold its GP Stakes unit into Strategic Partners underscores the clear synergies between the two strategies – though a few questions remain.
Side Letter: PE hires a politicianRishi Sunak's former deputy prime minister has joined forces with a UK private equity firm. Plus: Coller Capital is getting in on the evergreen action; and AXA IM is reaping the rewards of opening its NAV unit to third-party capital. Here's today's brief, for our valued subscribers only.
Neuberger Berman: Secondaries buyers could find themselves in China’s ‘best vintage’China funds are trading at a 50% discount to NAV even after a decline in private markets valuations, managing director Kent Chen tells PEI.
All eyes on artificial intelligence: Story of the YearAI-powered private equity was all the rage in 2023. Market sources expect to see increased adoption and new approaches to the technology over the coming year.
Side Letter: Carlyle's fundraising shortfallCarlyle's latest flagship has fallen well short of its target. Plus: why secondaries are taking off in China; and the NAV lending space gets another entrant. Here's today's brief, for our valued subscribers only.
Schroders taps 40% discounts on China’s RMB secondariesA mismatch between the supply of potential deals and the number of institutional buyers has given Schroders significant 'bargaining power', Jun Qian, the firm's head of China PE, tells PEI.
Side Letter: Florida SBA's secondaries schemeA shift in the LP/GP power balance in favour of LPs is spurring Florida SBA to buy second-hand fund stakes. Plus: Takeaways from last week's BVCA summit; and LPs are facing a brain drain. Here's today's brief, for our valued subscribers only.
Side Letter: Top fundraising tips revealedHot tips from IR professionals on how to keep LPs engaged. Plus: PE investment in Asia healthcare is down and another firm lowers its fundraising target. Here's today's brief, for our valued subscribers only.
The march of the US mid-marketLow entry multiples, high growth and an unconstrained exit environment mean small deals are becoming big business